Jeffrey A. Meckler - 10 Apr 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffrey Meckler
Issuer symbol
INDP
Transactions as of
10 Apr 2025
Net transactions value
-$504
Form type
4
Filing time
11 Apr 2025, 16:15:21 UTC
Previous filing
26 Nov 2024
Next filing
16 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Disposed to Issuer $176 -4,750 -100% $0.0370 0 10 Apr 2025 Common Stock 4,750 $536.00 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $139 -3,750 -100% $0.0370 0 10 Apr 2025 Common Stock 3,750 $24.60 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $30.08 -813 -100% $0.0370 0 10 Apr 2025 Common Stock 813 $425.60 Direct F1
transaction INDP sStock Option (right to buy) Disposed to Issuer $55.5 -1,500 -100% $0.0370 0 10 Apr 2025 Common Stock 1,500 $425.60 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $57.83 -1,563 -100% $0.0370 0 10 Apr 2025 Common Stock 1,563 $611.20 Direct F1
transaction INDP Stock Option (right to buy) Disposed to Issuer $46.25 -1,250 -100% $0.0370 0 10 Apr 2025 Common Stock 1,250 $355.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.